Bioenergetic disruption of human micro-vascular endothelial cells by antipsychotics

被引:29
作者
Elmorsy, Ekramy [1 ,2 ,3 ]
Smith, Paul A. [1 ]
机构
[1] Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2UH, England
[2] Mansoura Univ, Fac Med, Dept Forens Med, Mansoura, Egypt
[3] Mansoura Univ, Fac Med, Dept Clin Toxicol, Mansoura, Egypt
关键词
Antipsychotics; Mitochondria; Blood brain barrier; Endothelia; Heterogeneity; Toxicology; BLOOD-BRAIN-BARRIER; COMPLEX-I; RESPIRATORY-CHAIN; MITOCHONDRIAL; HALOPERIDOL; INHIBITION; VITRO; NEUROLEPTICS; CLOZAPINE; TISSUES;
D O I
10.1016/j.bbrc.2015.03.122
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antipsychotics (APs) are widely used medications, however these are not without side effects such as disruption of blood brain barrier function (BBB). To investigate this further we have studied the chronic effects of the typical APs, chlorpromazine (CPZ) and haloperidol (HAL) and the atypical APs, risperidone (MS) and clozapine (CLZ), on the bioenergetics of human micro-vascular endothelial cells (HBVECs) of the BBB. Alamar blue (AB) and ATP assays showed that these APs impair bioenergenesis in HBVECs in a concentration and time dependent manner. However since these effects were incomplete they suggest a population of cell bioenergetically heterogeneous, an idea supported by the bistable nature by which APs affected the mitochondria] transmembrane potential. CPZ, HAL and CLZ inhibited the activity of mitochondrial complexes I and III. Our data demonstrates that at therapeutic concentrations, APs can impair the bioenergetic status of HBVECs, an action that help explains the adverse side effects of these drugs when used clinically. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:857 / 862
页数:6
相关论文
共 25 条
[1]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[2]   Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation [J].
Balijepalli, S ;
Boyd, MR ;
Ravindranath, V .
NEUROPHARMACOLOGY, 1999, 38 (04) :567-577
[3]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517
[4]  
Daunt M., 2005, CELLS ENDOCRINOL, V147, P1527
[5]   Antipsychotic-associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia? [J].
Dean, CE .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02) :174-189
[6]   Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood-brain barrier [J].
Elmorsy, Ekramy ;
Elzalabany, Laila M. ;
Elsheikha, Hany M. ;
Smith, Paul A. .
BRAIN RESEARCH, 2014, 1583 :255-268
[7]   The Krebs cycle meets the cell cycle: Mitochondria and the G1-S transition [J].
Finkel, Toren ;
Hwang, Paul M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (29) :11825-11826
[8]  
GOFF DC, 1995, AM J PSYCHIAT, V152, P1730
[9]   Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro [J].
Heiser, Philip ;
Enning, Frank ;
Krieg, Juergen Christian ;
Vedder, Helmut .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (08) :851-856
[10]   In vitro inhibition of mitochondrial respiratory rate by antidepressants [J].
Hroudova, Jana ;
Fisar, Zdenek .
TOXICOLOGY LETTERS, 2012, 213 (03) :345-352